<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cardiothorac Surg</journal-id><journal-id journal-id-type="iso-abbrev">J Cardiothorac Surg</journal-id><journal-title-group><journal-title>Journal of Cardiothoracic Surgery</journal-title></journal-title-group><issn pub-type="epub">1749-8090</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23607780</article-id><article-id pub-id-type="pmc">3639066</article-id><article-id pub-id-type="publisher-id">1749-8090-8-107</article-id><article-id pub-id-type="doi">10.1186/1749-8090-8-107</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>N-acetylcysteine attenuates cardiopulmonary bypass-induced lung injury in dogs</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Qu</surname><given-names>Xianfeng</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>xianfeng_qu@126.com</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Li</surname><given-names>Qianyu</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>qianyuli754@163.com</email></contrib><contrib contrib-type="author" corresp="yes" id="A3"><name><surname>Wang</surname><given-names>Xiaofei</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>xiaofei_wangtz@163.com</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Yang</surname><given-names>Xiaoping</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>yingjielivip@163.com</email></contrib><contrib contrib-type="author" corresp="yes" id="A5"><name><surname>Wang</surname><given-names>Dongguo</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>docwangdg@126.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Anesthesiology, Taizhou Municipal Hospital, Taizhou, Zhejiang, 318000, P. R. China</aff><aff id="I2"><label>2</label>Clinical Laboratory, Taizhou Municipal Hospital, Taizhou, Zhejiang, 318000, P. R. China</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>22</day><month>4</month><year>2013</year></pub-date><volume>8</volume><fpage>107</fpage><lpage>107</lpage><history><date date-type="received"><day>1</day><month>12</month><year>2012</year></date><date date-type="accepted"><day>12</day><month>4</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Qu et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Qu et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.cardiothoracicsurgery.org/content/8/1/107"/><abstract><sec><title>Background</title><p>Cardiopulmonary bypass (CPB) is usually associated with inflammatory response that leads to various degrees of organ dysfunction in multiple systems, including lung injury. Our previous study showed that transforming growth factor beta1 (TGF&#x003b2;1) was involved in CPB-induced lung injury. N-acetylcysteine (NAC) is an antioxidant and is able to prevent CPB-induced pneumocyte apoptosis through scavenging radical. Therefore, we investigated whether NAC may attenuate CPB-induced lung injury by inhibiting TGF&#x003b2;1 expression.</p></sec><sec><title>Methods</title><p>Fifty-four 18 to 24-month-old mongrel dogs (15&#x02013;16&#x000a0;kg) were randomly divided into control group, CPB group and NAC group (n&#x02009;=&#x02009;18). Six dogs in each group were killed prior to, as well as 30 and 60&#x000a0;minutes after the operation (T0, T1 and T2). Lung injury was evaluated by hematoxylin and eosin (H&#x00026;E) staining. Respiratory index (RI), oxygenation index (OI), malondialdehyde (MDA) content and superoxide dismutase (SOD) activity in the lung were determined at each time point. TGF&#x003b2;1 expression was determined using real time RT-PCR and immunohistochemistry.</p></sec><sec><title>Results</title><p>A serious lung injury was observed after CPB in dogs. RI and MDA content were increased significantly after CPB, whereas OI and SOD activity were decreased. H&#x00026;E staining showed that NAC treatment obviously attenuated CPB-induced lung injury. NAC treatment upregulated OI and SOD activity and downregulated RI and MDA content in the lung tissues of dogs after CPB. Treatment with NAC significantly suppressed the TGF&#x003b2;1 expression in the lung tissues at both mRNA and protein levels.</p></sec><sec><title>Conclusion</title><p>Our results suggest that NAC is a potent agent against CPB-induced acute lung injury through inhibiting TGF&#x003b2;1 expression.</p></sec></abstract><kwd-group><kwd>N-acetylcysteine</kwd><kwd>Cardiopulmonary bypass</kwd><kwd>Respiratory distress syndrome</kwd><kwd>Adult</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Cardiopulmonary bypass (CPB), which is an essential technique for cardiac surgery, usually induces acute lung injury [<xref ref-type="bibr" rid="B1">1</xref>]. Lung injury clinically affects a small number of patients who undergo CPB. It is part of the CPB-induced organ dysfunction that may cause a collapsed lung and may develop into acute respiratory distress syndrome (ARDS) [<xref ref-type="bibr" rid="B1">1</xref>]. Therefore, CPB-induced acute lung injury is one of the main reasons for death after cardiac surgery [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>Transforming growth factor beta1 (TGF&#x003b2;1), a cytokine with complex functions, is able to regulate cell growth, proliferation and differentiation, and participate in the inflammatory response and tissue repair [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. It has been reported that TGF&#x003b2;1 participates in the endotoxin-induced acute lung injury through TGF&#x003b2;1-Smad<sub>2</sub> pathway [<xref ref-type="bibr" rid="B7">7</xref>]. TGF&#x003b2;1 is abundantly expressed in the bronchoalveolar lavage fluid of the patients with ARDS during the early stage [<xref ref-type="bibr" rid="B8">8</xref>]. In our previous work, we also found the expression of TGF&#x003b2;1 was upregulated in CPB-induced acute lung injury in dogs. It can directly increase the permeability of pulmonary artery endothelial cells and alveolar epithelial cells, resulting in the formation of pulmonary edema, the releasing of proinflammatory cytokines and thereby aggravating lung injury [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>]. TGF&#x003b2;1 also participates in the progression of lung fibrosis following injury [<xref ref-type="bibr" rid="B12">12</xref>]. Furthermore, TGF&#x003b2;1 may aggravate the lung injury through increasing endothelial [<xref ref-type="bibr" rid="B13">13</xref>] and epithelial permeability [<xref ref-type="bibr" rid="B14">14</xref>] and decreasing ion and fluid transport [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. In view of the important role of TGF&#x003b2;1 in the development of acute lung injury, inhibition of TGF&#x003b2;1 may be a potential therapeutic strategy for reducing CPB-induced acute lung injury.</p><p>N-acetylcysteine (NAC) is an antioxidant that could scavenge oxygen free radicals with protective effects on cells and microcirculation [<xref ref-type="bibr" rid="B17">17</xref>]. NAC is able to alleviate lung reperfusion injury induced by deep hypothermic circulatory arrest through scavenging oxygen free radicals [<xref ref-type="bibr" rid="B18">18</xref>]. It can reduce the pulmonary vascular resistance index and decrease the incidence of lung injury after off-pump coronary artery bypass surgery [<xref ref-type="bibr" rid="B19">19</xref>]. Interestingly, NAC can also prevent CPB-induced pneumocyte apoptosis through scavenging radical [<xref ref-type="bibr" rid="B20">20</xref>]. However, the relationship between NAC treatment and TGF&#x003b2;1 expression in lung tissues has not been reported. In view of the important role of TGF&#x003b2;1 during the progression of acute lung injury, the objective of this work was to investigate whether NAC could exert a protective effect on CPB-induced acute lung injury through inhibiting the expression of TGF&#x003b2;1.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Animals and experiment design</title><p>Fifty-four 18 to 24-month-old mongrel dogs (15&#x02009;~&#x02009;16&#x000a0;kg) were purchased from the Experimental animal center of Zhejiang University. These dogs were randomly assigned into the control group, CPB group and NAC group (n&#x02009;=&#x02009;18). Dogs were anesthetized with 2% sodium pentobarbital (i.p., 30&#x000a0;mg&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>), placed on a constant-temperature operating table and then endotracheal intubation was carried out. The animal was placed on an AH-II animal ventilator (Beijing science and Technology Development Company, Beijing, China) in the volume control mode. Initial ventilatory settings included: FIO<sub>2</sub> 1.0, delivered tidal volume measured at the endotracheal tube 12&#x000a0;ml&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>. The respiratory rate (RR) was adjusted according to the result of blood gas analysis to maintain the PaCO2 between 35 and 40&#x000a0;mmHg. Mean arterial pressure (MAP) and central venous pressure (CVP) were monitored by an Intellivue MP50type multifunctional monitor (Philips, Holland) through placing femoral arterial and femoral venous catheters. Anesthesia was maintained with a continuous infusion of fentanyl (100&#x000a0;&#x003bc;g&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>&#x02009;&#x000b7;&#x02009;min<sup>-1</sup>). Intermittent boluses of vecuronium bromide (0.1&#x000a0;mg&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>) was administered for neuromuscular blockade. The lung injury after CPB was induced according to the method reported by Williams <italic>et al.</italic>[<xref ref-type="bibr" rid="B21">21</xref>]. Briefly, after a median sternotomy, the pericardium was incised. After administration of heparin (3&#x000a0;mg&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>), cannulation was accomplished by placing an 8-French infant arterial cannula in the ascending aorta and a single 22-French venous cannula in the right atrium. Each dog was placed on conventional nonpulsatile CPB at a flow of (125&#x000a0;ml&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>&#x02009;&#x000b7;&#x02009;min<sup>-1</sup>). Five minutes later, each animal was cooled for 10 mins to a nasopharyngeal temperature of 25&#x000b0;C. After cooling, the bypass flow was adjusted to 35&#x000a0;ml&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>&#x02009;&#x000b7;&#x02009;min<sup>-1</sup> for 60 mins, which achieved a mean arterial pressure of 35 ~45&#x000a0;mm Hg. During this period of low-flow CPB, the ventilator was set to deliver a constant positive airway pressure of 10&#x000a0;cm H<sub>2</sub>O with the FIO<sub>2</sub> decreased to 0.21. After the 60-min period of low-flow CPB, the ventilator settings were adjusted to FIO<sub>2</sub> 1.0, delivered tidal volume of 12&#x000a0;ml&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>. After rewarming to 37&#x000a0;&#x000b0;C for 20 mins, the animals were removed from CPB. Post CPB, adrenaline (1:1000, 0.1&#x000a0;ml&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>) and dopamine (10&#x000a0;&#x003bc;g&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>&#x02009;&#x000b7;&#x02009;min<sup>-1</sup>) were administered for 60&#x000a0;min by a venous pump. Dogs in the control group underwent the same operation except for CPB. The dogs in NAC group were injected intravenously with NAC (Batch No. 2009081606, Sigma, USA) (150&#x000a0;mg&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>) through femoral vein before CPB according to the method in reference [<xref ref-type="bibr" rid="B22">22</xref>]. Then the dogs were continuously infused with NAC (20&#x000a0;mg&#x02009;&#x000b7;&#x02009;kg<sup>-1</sup>&#x02009;&#x000b7;&#x02009;h<sup>-1</sup>) during the CPB process until the end of the experiment. The dogs in control group and CPB group were injected with equivalent normal saline. Six dogs in each group were sacrificed before CPB (T0), 30&#x000a0;min after CPB (T1) and 60&#x000a0;min after CPB (T2) and 2&#x000a0;ml arterial blood was obtained from each dog at each time point. Pulmonary tissues were sampled for future determination. The experiments were performed in accordance with the Helsinki Declaration of 1975 and approved by the Ethics Committee of Taizhou University Medical School. All the animals used in the study received humane care.</p><p>Respiratory index (RI) and oxygenation index (OI) were determined with the arterial blood using a GEMpremier &#x02122;3000 Blood gas analyzer (Instrumentation Laboratory, Ann Arbor, Michigan, USA).</p><p>Malondialdehyde (MDA) content and SOD activity of lung were measured using the thiobarbituric sodium method and xanthine oxidase method, respectively. Briefly, after the lung tissues were rinsed in pre-cool saline to remove the blood, the lung tissues were weighed and homogenized in 9 times the volume of homogenate medium (saline) using a Soniprep150 ultrasonic disintegrator (MSE company, United States). Then the homogenate was centrifuged at 3000&#x000a0;g for 12&#x000a0;min and supernatant was saved. The MDA content and SOD activity were measured with commercial kits from Nanjin Jiancheng Bioengineering Institute (Nanjing, China) using BeckmanDU800 (Beckman company, the United States of America) visible light analyzer.</p></sec><sec><title>Hematoxylin and Eosin Staining</title><p>Pulmonary tissues were fixed with 4% paraformaldehyde, embedded in paraffin and stained with Hematoxylin and Eosin Staining (H&#x00026;E) [<xref ref-type="bibr" rid="B23">23</xref>]. The images were obtained with a Leica DM1000 optical microscope and the pulmonary injury was scored by a blinded observer according to the following criteria [<xref ref-type="bibr" rid="B24">24</xref>]: alveolar congestion, hemorrhage, infiltration or aggregation of neutrophils in the airspace or vessel wall, and thickness of the alveolar wall. Each item was graded according to a 5-point scale: 0, minimal (little) damage; 1, mild damage; 2, moderate damage; 3, severe damage; and 4, maximum damage. Thus, minimum and maximum possible scores were 0 and 16, respectively.</p></sec><sec><title>Immunohistochemistry</title><p>The expression of TGF&#x003b2;1 was determined by immunohistochemical (IHC) staining with a commercial Strept Actividin-Biotin Complex (SABC) kit (Zhongshan Biological Technology, Beijing, China). IHC was carried out using a specific polyclonal anti- TGF&#x003b2;1 antibody (1:150, Santa Cruz Biotech, Santa Cruz, CA, USA). The images were obtained with a Leica DM1000 optical microscope and analyzed by the image analysis system, Image-Pro Plus5.1.0.20 (Media Cybernetics, Silver Spring, MD, USA). Five unduplicated fields were selected in one slide.</p></sec><sec><title>RNA extraction and semi-quantitative RT-PCR</title><p>Total RNA was extracted from pulmonary tissues with TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manual. The concentration and purity of total RNA were determined by a spectrophotometer (Eppendorf, Hamburg, Germany). Reverse transcription was performed using oligo (dT) primer RT mixtures with M-MLV (Promega, Madison, WI, USA) reverse transcriptase 200 U/20&#x000a0;&#x003bc;l, total RNA 1&#x000a0;&#x003bc;g/20&#x000a0;&#x003bc;l. cDNA was stored at &#x02212;20&#x000b0;C. Primers used in the PCR reaction were as follows: &#x003b2;-actin, forward: 5&#x02032;- GTA AAG ACC TCT ATG CCA ACA -3&#x02032;, reverse: 5&#x02032;- CTG GAA GGT GGA CAG TGA G -3&#x02032;; TGF&#x003b2;1: forward: 5&#x02032; &#x02013;TAA TGG TGG ACC GCA ACA AC -3&#x02032;, reverse: 5&#x02032;- GTG AGC ACT GAA GCG AAA GC -3&#x02032;. PCR reaction was performed with 2&#x000a0;&#x003bc;l of cDNA, 1 u Taq DNA Polymerase (Fermentas, MBI, USA) and 0.5&#x000a0;&#x003bc;mol/L of forward and reverse primers, for a total volume of 20&#x000a0;&#x003bc;l. Reactions were started with a polymerase activation step at 94&#x000b0;C for 1&#x000a0;min followed by 30&#x000a0;cycles of 94&#x000b0;C for 1&#x000a0;min, 54&#x000a0;C for 1&#x000a0;min and 72&#x000b0;C for 1&#x000a0;min, and elongation at 72&#x000b0;C for 10&#x000a0;min. The PCR products were electrophoresed on a 1.5% agarose gel in the presence of ethidium bromide, and absorbance was measured by an image analysis system. The ratio of targets to &#x003b2;-actin was used to evaluate the significance of the difference between the two groups.</p></sec><sec><title>Statistical analysis</title><p>Statistical significance was determined using SPSS 13.0 for Windows. Measurement data are expressed as means&#x02009;&#x000b1;&#x02009;S.D. Student&#x02019;s t-test was performed to detect any differences between the two groups. Count data are expressed as median (range) and the difference in lung injury score between the two groups was tested using Kruskal-Wallis rank sum test. Differences were deemed significant if <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>NAC attenuated CPB-induced lung injury</title><p>To investigate the effect of NAC on CPB-induced lung injury, H&#x00026;E staining was performed. As shown in Figure&#x000a0;<xref ref-type="fig" rid="F1">1</xref>, fine structure of lung was observed in the control group, without inflammatory cells infiltration. Smooth and complete pulmonary alveolar wall without bleeding and exudate in the pulmonary alveolar and interstitial was also observed in the lung tissues of control group (Figure&#x000a0;<xref ref-type="fig" rid="F1">1</xref>). In the CPB group, disorder of the structure of lung tissues, and a large amount of fluid and a number of red blood cells in the pulmonary alveolar wall were observed. Marked hyperemia in the pulmonary alveolar wall, thickening of alveolar septa, edema in the pulmonary interstitium, extensive infiltration of inflammatory cells and focal atelectasis were also observed. With the treatment of NAC, the destruction on the lung structure was obviously reduced and little inflammatory cells were observed. The pulmonary injury score of NAC group was much lower than that of CPB group (Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>HE staining of lung tissues.</bold> HE staining was performed to detect the lung injury of dogs at three different time points. Six dogs in each group were examined (&#x000d7;200).</p></caption><graphic xlink:href="1749-8090-8-107-1"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p><bold>The scores of lung injury at T2 time point (</bold><bold><italic>n</italic></bold>&#x02009;<bold>=&#x02009;6)</bold></p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col/></colgroup><thead valign="top"><tr><th align="left"><bold>Group</bold></th><th align="center"><bold>Lung injury score</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Control<hr/></td><td align="center" valign="bottom">0.5 (0&#x02013;1)<hr/></td></tr><tr><td align="left" valign="bottom">CPB<hr/></td><td align="center" valign="bottom">10.5 (7&#x02013;14) <sup>a</sup><hr/></td></tr><tr><td align="left">NAC</td><td align="center">4 (2&#x02013;5) <sup>b</sup></td></tr></tbody></table><table-wrap-foot><p>Data are expressed as median (range). Compared with control group, <sup>a</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; compared with CPB group, <sup>b</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></table-wrap-foot></table-wrap></sec><sec><title>NAC regulated RI and OI post operation</title><p>There were no significant changes of RI and OI in control group post operation (Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>). Compared with the values at T<sub>0</sub> time point, RI values of CPB and NAC groups were increased, while OI values were decreased (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) at T<sub>1</sub> and T<sub>2</sub> time points. The RI values of NAC group were lower and the OI values of NAC group were higher at T<sub>1</sub> and T<sub>2</sub> time points than those of CPB group, respectively.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Effect of NAC on the levels of RI and OI</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th rowspan="2" align="center" valign="top"><bold>Group</bold></th><th colspan="3" align="center" valign="bottom"><bold>RI</bold><hr/></th><th colspan="3" align="center" valign="bottom"><bold>OI</bold><hr/></th></tr><tr><th align="center"><bold>T0</bold></th><th align="center"><bold>T1</bold></th><th align="center"><bold>T2</bold></th><th align="center"><bold>T0</bold></th><th align="center"><bold>T1</bold></th><th align="center"><bold>T2</bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom">Control<hr/></td><td align="center" valign="bottom">0.72&#x02009;&#x000b1;&#x02009;0.03<hr/></td><td align="center" valign="bottom">0.74&#x02009;&#x000b1;&#x02009;0.33<hr/></td><td align="center" valign="bottom">0.75&#x02009;&#x000b1;&#x02009;0.43<hr/></td><td align="center" valign="bottom">422&#x02009;&#x000b1;&#x02009;25<hr/></td><td align="center" valign="bottom">417&#x02009;&#x000b1;&#x02009;27<hr/></td><td align="center" valign="bottom">420&#x02009;&#x000b1;&#x02009;23<hr/></td></tr><tr><td align="center" valign="bottom">CPB<hr/></td><td align="center" valign="bottom">0.71&#x02009;&#x000b1;&#x02009;0.04<hr/></td><td align="center" valign="bottom">4.71&#x02009;&#x000b1;&#x02009;0.55 <sup>ab</sup><hr/></td><td align="center" valign="bottom">5.10&#x02009;&#x000b1;&#x02009;0.13 <sup>ab</sup><hr/></td><td align="center" valign="bottom">420&#x02009;&#x000b1;&#x02009;26<hr/></td><td align="center" valign="bottom">272&#x02009;&#x000b1;&#x02009;25 <sup>ab</sup><hr/></td><td align="center" valign="bottom">220&#x02009;&#x000b1;&#x02009;22 <sup>ab</sup><hr/></td></tr><tr><td align="center">NAC</td><td align="center">0.75&#x02009;&#x000b1;&#x02009;0.04</td><td align="center">0.79&#x02009;&#x000b1;&#x02009;0.41 <sup>ac</sup></td><td align="center">1.07&#x02009;&#x000b1;&#x02009;0.63 <sup>ac</sup></td><td align="center">425&#x02009;&#x000b1;&#x02009;27</td><td align="center">318&#x02009;&#x000b1;&#x02009;26 <sup>abc</sup></td><td align="center">306&#x02009;&#x000b1;&#x02009;26 <sup>abc</sup></td></tr></tbody></table><table-wrap-foot><p>Blood samples were obtained from femoral artery at indicated time points and then RI and OI were analyzed. Data are expressed as means&#x02009;&#x000b1;&#x02009;S.D (n&#x02009;=&#x02009;6). Compared with T0 time point, <sup>a</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; compared with control group, <sup>b</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; compared with CPB group, <sup>c</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></table-wrap-foot></table-wrap></sec><sec><title>NAC regulated MDA and SOD post operation</title><p>The MDA levels and the SOD activity are considered as indicators of lipid peroxidation [<xref ref-type="bibr" rid="B25">25</xref>]. Therefore, we examined the MDA content and the SOD activity in the dogs&#x02019; lung tissues at different time points (Table&#x000a0;<xref ref-type="table" rid="T3">3</xref>). There were no obvious changes in MDA content and SOD activity in control group post the operation. The MDA content of lung tissues in CPB group was increased significantly after CPB, while treatment with NAC inhibited the increase of MDA content. In addition, there was a significant decrease of SOD activity in the CPB group at T1 and T2 time points compared with that at T0 time point. However, the decrease of SOD activity was significantly reversed by NAC treatment.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Effect of NAC on the MDA and SOD levels at different time points</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th rowspan="2" align="center" valign="top"><bold>Group</bold></th><th colspan="3" align="center" valign="bottom"><bold>MDA (nmol/mg)</bold><hr/></th><th colspan="3" align="center" valign="bottom"><bold>SOD (U/mg)</bold><hr/></th></tr><tr><th align="center"><bold>T0</bold></th><th align="center"><bold>T1</bold></th><th align="center"><bold>T2</bold></th><th align="center"><bold>T0</bold></th><th align="center"><bold>T1</bold></th><th align="center"><bold>T2</bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom">Control<hr/></td><td align="center" valign="bottom">10.5&#x02009;&#x000b1;&#x02009;1.0<hr/></td><td align="center" valign="bottom">10.8&#x02009;&#x000b1;&#x02009;1.1<hr/></td><td align="center" valign="bottom">10.9&#x02009;&#x000b1;&#x02009;1.2<hr/></td><td align="center" valign="bottom">154.7&#x02009;&#x000b1;&#x02009;3. 9<hr/></td><td align="center" valign="bottom">150. 8&#x02009;&#x000b1;&#x02009;4.8<hr/></td><td align="center" valign="bottom">151.69&#x02009;&#x000b1;&#x02009;2.7<hr/></td></tr><tr><td align="center" valign="bottom">CPB<hr/></td><td align="center" valign="bottom">12.3&#x02009;&#x000b1;&#x02009;1.5<hr/></td><td align="center" valign="bottom">25.8&#x02009;&#x000b1;&#x02009;1.9 <sup>aabb</sup><hr/></td><td align="center" valign="bottom">24.9&#x02009;&#x000b1;&#x02009;1.8 <sup>aabb</sup><hr/></td><td align="center" valign="bottom">153.6&#x02009;&#x000b1;&#x02009;4.9<hr/></td><td align="center" valign="bottom">76.9&#x02009;&#x000b1;&#x02009;3.8<sup>aa</sup><hr/></td><td align="center" valign="bottom">82.2&#x02009;&#x000b1;&#x02009;3.1<sup>aa</sup><hr/></td></tr><tr><td align="center">NAC</td><td align="center">11.6&#x02009;&#x000b1;&#x02009;1.0</td><td align="center">16.5&#x02009;&#x000b1;&#x02009;2.4 <sup>abbcc</sup></td><td align="center">16.2&#x02009;&#x000b1;&#x02009;2.1 <sup>abbcc</sup></td><td align="center">150.7&#x02009;&#x000b1;&#x02009;2.2</td><td align="center">97.3&#x02009;&#x000b1;&#x02009;2.4<sup>aabbcc</sup></td><td align="center">98.5&#x02009;&#x000b1;&#x02009;3.6<sup>aabbcc</sup></td></tr></tbody></table><table-wrap-foot><p>Data are expressed as means&#x02009;&#x000b1;&#x02009;S.D (n&#x02009;=&#x02009;6). Compared with T<sub>0</sub> time point, <sup>a</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>aa</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; compared with control group, <sup>b</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>bb</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; compared with CPB group, <sup>c</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>cc</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01.</p></table-wrap-foot></table-wrap></sec><sec><title>NAC inhibited the TGF&#x003b2;<sub>1</sub> expression in the lung tissues</title><p>To investigate the effect of NAC on the expression of TGF&#x003b2;1 in lung tissues, we performed RT-PCR and immunohistochemistry. The expression of TGF&#x003b2;1 mRNA increased significantly after CPB compared with those of control (Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>). TGF&#x003b2;1 protein was also overexpressed in the lung tissues of dogs in CPB group after CPB as shown by immunohistochemical staining (Figure&#x000a0;<xref ref-type="fig" rid="F3">3</xref>). Treatment with NAC significantly suppressed the TGF&#x003b2;1 expression in the lung tissues at both mRNA and protein levels.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Expression of TGF&#x003b2;1 mRNA levels at each time point.</bold> After the dogs were killed at each time points, total RNA of lung was isolated. Semi RT-PCR was performed to detect the TGF&#x003b2;1 mRNA expression. <bold>A</bold>. Agarose gel electrophoresis of TGF&#x003b2;1 and &#x003b2;-actin; <bold>B</bold>. Quantities for densitometric analysis of TGF&#x003b2;1 mRNA. Data are expressed as mean&#x02009;&#x000b1;&#x02009;S.D. (n&#x02009;=&#x02009;6). ** <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, compared with control; <sup>##</sup><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, compared with CPB.</p></caption><graphic xlink:href="1749-8090-8-107-2"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Expression of TGF&#x003b2;1 in the lung tissues at each time point.</bold> Expression of TGF&#x003b2;1 in lung tissues was determined by immunohistochemistry (&#x000d7;200).</p></caption><graphic xlink:href="1749-8090-8-107-3"/></fig></sec></sec><sec><title>Discussions</title><p>In the present study, we investigated the effect of NAC on CPB-induced acute lung injury. NAC reduced the pathological injury of the lung tissues in dogs. NAC treatment reversed CPB-induced upregulation of RI and MDA content, and downregulation of OI and SOD activity. CPB-induced expression of TGF&#x003b2;1 in the lung of dogs was also inhibited by NAC treatment. The results showed that treatment with NAC attenuated the CPB-induced lung injury, indicating that NAC may be a potential drug for CPB-induced lung injury.</p><p>MDA is the end-products of lipid peroxidation and is considered as an indicator of the extent of lipid peroxidation, as well as the degree of tissue injury induced by oxygen free radicals. SOD is an oxygen free radical scavenger, reflecting the ability of scavenging oxygen free radicals. NAC, a micromolecule containing active hydrosulfide (&#x02212;SH) with molecular weight of 163.29&#x000a0;g&#x000a0;mol<sup>-1</sup>, could be quickly absorbed into the cells. As a sulfhydryl donor,it can scavenge oxygen free radicals and play a role in antioxidation directly. In addition, it could be converted to cysteine by stripping acetyl. Cysteine is the precursor of reduced glutathione hormone (GSH) which is able to scavenge oxygen free radicals [<xref ref-type="bibr" rid="B26">26</xref>]. Thus, NAC can also exert antioxidant effect indirectly. In the present study, our results showed that the MDA level was upregulated, while the SOD activity was downregulated in the lung tissues of dogs after CPB. In consistent with previous study [<xref ref-type="bibr" rid="B20">20</xref>], treatment with NAC significantly improved the lipid peroxidation injury in the lung tissues after CPB, indicating NAC may play a protective role in CPB-induced acute lung injury through its antioxidant effect.</p><p>TGF&#x003b2;1 has been shown to be a critical mediator of acute lung injury [<xref ref-type="bibr" rid="B14">14</xref>]. The upregulation of TGF&#x003b2;1 is usually related with the increase of the permeability of pulmonary endothelial monolayers and the permeability of alveolar epithelial monolayers [<xref ref-type="bibr" rid="B8">8</xref>]. The upregulation of TGF&#x003b2;1 also leads to the decrease of sodium channel ENaC on the apical surface of alveolar epithelial cells [<xref ref-type="bibr" rid="B15">15</xref>], subsequently impairing the removal of salt and water from the alveolar lumen. Interestingly, it has also been reported that oxygen free radicals could activate pro-inflammatory nuclear factors, such as NF-&#x003ba;B and AP-1, and subsequently induce the expression of TGF&#x003b2;1 [<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B30">30</xref>]. Therefore, increased oxygen free radicals level in the injured lung tissues after CPB potentially lead to the upregulation of TGF&#x003b2;1. Furthurmore, TGF&#x003b2;1 could promote the release of oxygen free radicals to form the infernal circle of oxygen free radical-TGF&#x003b2;1-lung injury. In the present study, we found NAC could not only inhibit the lipid peroxidation injury, but also inhibit the upregulation of TGF&#x003b2;1 in the lung tissues of dogs after CPB, indicating that scavenging oxygen free radicals, attenuating lipid peroxidation, downregulating TGF<italic>&#x003b2;</italic><sub>1</sub> expression in the lung tissues and thereby blocking the infernal circle of oxygen free radical-TGF&#x003b2;1-lung injury may be the mechanisms involved in the protective effect of NAC on CPB-induced acute lung injury in dogs.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In conclusion, our results showed that NAC could alleviate the acute lung injury induced by CPB in dogs. The underlying mechanisms include scavenging oxygen free radicals and downregulating TGF&#x003b2;1 expression in the lung tissues after CPB. Our results suggest that NAC is a potent agent against CPB-induced acute lung injury.</p></sec><sec><title>Abbreviations</title><p>ARDS: Acute respiratory distress syndrome; CPB: Cardiopulmonary bypass; CVP: Central venous pressure; GSH: Glutathione hormone; H&#x00026;E: Hematoxylin and eosin; IHC: Immunohistochemical; MDA: Malondialdehyde; MAP: Mean arterial pressure; NAC: N-acetylcysteine; OI: Oxygenation index; RI: Respiratory index; RR: Respiratory rate; SABC: Strept Actividin-Biotin Complex; SOD: Superoxide dismutase; TGF&#x003b2;1: Transforming growth factor beta1.</p></sec><sec><title>Competing interests</title><p>The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.</p></sec><sec><title>Authors&#x02019; contributions</title><p>DW designed research; XQ, QL and XW performed research; XY analyzed data; DW and XW wrote the paper. All authors read and approved the final manuscript.</p></sec></body><back><sec><title>Acknowledgments</title><p>This work was supported by the Medical Science Foundation of Department of Public Health, Zhejiang Province (2008B203) and the Foundation of science and Technology bureau of Taizhou (090KY40).</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Asimakopoulos</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>PL</given-names></name><name><surname>Ratnatunga</surname><given-names>CP</given-names></name><name><surname>Taylor</surname><given-names>KM</given-names></name><article-title>Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass</article-title><source>Ann Thorac Surg</source><year>1999</year><volume>68</volume><fpage>1107</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1016/S0003-4975(99)00781-X</pub-id><pub-id pub-id-type="pmid">10510030</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Canet</surname><given-names>J</given-names></name><name><surname>Gallart</surname><given-names>L</given-names></name><name><surname>Gomar</surname><given-names>C</given-names></name><name><surname>Paluzie</surname><given-names>G</given-names></name><name><surname>Valles</surname><given-names>J</given-names></name><name><surname>Castillo</surname><given-names>J</given-names></name><name><surname>Sabate</surname><given-names>S</given-names></name><name><surname>Mazo</surname><given-names>V</given-names></name><name><surname>Briones</surname><given-names>Z</given-names></name><name><surname>Sanchis</surname><given-names>J</given-names></name><article-title>Prediction of postoperative pulmonary complications in a population-based surgical cohort</article-title><source>Anesthesiology</source><year>2010</year><volume>113</volume><fpage>1338</fpage><lpage>1350</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e3181fc6e0a</pub-id><pub-id pub-id-type="pmid">21045639</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Ahn</surname><given-names>JY</given-names></name><name><surname>Lim</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>MH</given-names></name><name><surname>Lee</surname><given-names>SL</given-names></name><name><surname>Yun</surname><given-names>YS</given-names></name><name><surname>Jeong</surname><given-names>G</given-names></name><name><surname>Song</surname><given-names>JY</given-names></name><article-title>Im-412 inhibits transforming growth factor beta-induced fibroblast differentiation in human lung fibroblast cells</article-title><source>Biochem Biophys Res Commun</source><year>2010</year><volume>399</volume><fpage>268</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.07.067</pub-id><pub-id pub-id-type="pmid">20655294</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Miyake</surname><given-names>T</given-names></name><name><surname>Alli</surname><given-names>NS</given-names></name><name><surname>McDermott</surname><given-names>JC</given-names></name><article-title>Nuclear function of smad7 promotes myogenesis</article-title><source>Mol Cell Biol</source><year>2010</year><volume>30</volume><fpage>722</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1128/MCB.01005-09</pub-id><pub-id pub-id-type="pmid">19995910</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Mishra</surname><given-names>L</given-names></name><name><surname>Derynck</surname><given-names>R</given-names></name><name><surname>Mishra</surname><given-names>B</given-names></name><article-title>Transforming growth factor-beta signaling in stem cells and cancer</article-title><source>Science</source><year>2005</year><volume>310</volume><fpage>68</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1126/science.1118389</pub-id><pub-id pub-id-type="pmid">16210527</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Wipff</surname><given-names>PJ</given-names></name><name><surname>Hinz</surname><given-names>B</given-names></name><article-title>Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship</article-title><source>Eur J Cell Biol</source><year>2008</year><volume>87</volume><fpage>601</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1016/j.ejcb.2008.01.012</pub-id><pub-id pub-id-type="pmid">18342983</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>WX</given-names></name><name><surname>Xue</surname><given-names>FS</given-names></name><name><surname>Zhou</surname><given-names>LJ</given-names></name><name><surname>Xu</surname><given-names>SQ</given-names></name><name><surname>Ding</surname><given-names>N</given-names></name><article-title>Early administration of propofol protects against endotoxin-induced acute lung injury in rats by inhibiting the tgf-beta1-smad2 dependent pathway</article-title><source>Inflamm Res</source><year>2010</year><volume>59</volume><fpage>491</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1007/s00011-009-0110-y</pub-id><pub-id pub-id-type="pmid">19941153</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Fahy</surname><given-names>RJ</given-names></name><name><surname>Lichtenberger</surname><given-names>F</given-names></name><name><surname>McKeegan</surname><given-names>CB</given-names></name><name><surname>Nuovo</surname><given-names>GJ</given-names></name><name><surname>Marsh</surname><given-names>CB</given-names></name><name><surname>Wewers</surname><given-names>MD</given-names></name><article-title>The acute respiratory distress syndrome: a role for transforming growth factor-beta 1</article-title><source>Am J Respir Cell Mol Biol</source><year>2003</year><volume>28</volume><fpage>499</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2002-0092OC</pub-id><pub-id pub-id-type="pmid">12654639</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Wesselkamper</surname><given-names>SC</given-names></name><name><surname>Case</surname><given-names>LM</given-names></name><name><surname>Henning</surname><given-names>LN</given-names></name><name><surname>Borchers</surname><given-names>MT</given-names></name><name><surname>Tichelaar</surname><given-names>JW</given-names></name><name><surname>Mason</surname><given-names>JM</given-names></name><name><surname>Dragin</surname><given-names>N</given-names></name><name><surname>Medvedovic</surname><given-names>M</given-names></name><name><surname>Sartor</surname><given-names>MA</given-names></name><name><surname>Tomlinson</surname><given-names>CR</given-names></name><name><surname>Leikauf</surname><given-names>GD</given-names></name><article-title>Gene expression changes during the development of acute lung injury: Role of transforming growth factor beta</article-title><source>Am J Respir Crit Care Med</source><year>2005</year><volume>172</volume><fpage>1399</fpage><lpage>1411</lpage><pub-id pub-id-type="doi">10.1164/rccm.200502-286OC</pub-id><pub-id pub-id-type="pmid">16100012</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Clements</surname><given-names>RT</given-names></name><name><surname>Minnear</surname><given-names>FL</given-names></name><name><surname>Singer</surname><given-names>HA</given-names></name><name><surname>Keller</surname><given-names>RS</given-names></name><name><surname>Vincent</surname><given-names>PA</given-names></name><article-title>Rhoa and rho-kinase dependent and independent signals mediate tgf-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2005</year><volume>288</volume><fpage>L294</fpage><lpage>L306</lpage><pub-id pub-id-type="pmid">15475381</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Birukova</surname><given-names>AA</given-names></name><name><surname>Birukov</surname><given-names>KG</given-names></name><name><surname>Adyshev</surname><given-names>D</given-names></name><name><surname>Usatyuk</surname><given-names>P</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><name><surname>Garcia</surname><given-names>JG</given-names></name><name><surname>Verin</surname><given-names>AD</given-names></name><article-title>Involvement of microtubules and rho pathway in tgf-beta1-induced lung vascular barrier dysfunction</article-title><source>J Cell Physiol</source><year>2005</year><volume>204</volume><fpage>934</fpage><lpage>947</lpage><pub-id pub-id-type="doi">10.1002/jcp.20359</pub-id><pub-id pub-id-type="pmid">15828024</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Broekelmann</surname><given-names>TJ</given-names></name><name><surname>Limper</surname><given-names>AH</given-names></name><name><surname>Colby</surname><given-names>TV</given-names></name><name><surname>McDonald</surname><given-names>JA</given-names></name><article-title>Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis</article-title><source>Proc Natl Acad Sci USA</source><year>1991</year><volume>88</volume><fpage>6642</fpage><lpage>6646</lpage><pub-id pub-id-type="doi">10.1073/pnas.88.15.6642</pub-id><pub-id pub-id-type="pmid">1862087</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Hurst</surname><given-names>VI</given-names></name><name><surname>Goldberg</surname><given-names>PL</given-names></name><name><surname>Minnear</surname><given-names>FL</given-names></name><name><surname>Heimark</surname><given-names>RL</given-names></name><name><surname>Vincent</surname><given-names>PA</given-names></name><article-title>Rearrangement of adherens junctions by transforming growth factor-beta1: Role of contraction</article-title><source>Am J Physiol</source><year>1999</year><volume>276</volume><fpage>L582</fpage><lpage>L595</lpage><pub-id pub-id-type="pmid">10198356</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Pittet</surname><given-names>JF</given-names></name><name><surname>Griffiths</surname><given-names>MJ</given-names></name><name><surname>Geiser</surname><given-names>T</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Dalton</surname><given-names>SL</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Brown</surname><given-names>LA</given-names></name><name><surname>Gotwals</surname><given-names>PJ</given-names></name><name><surname>Koteliansky</surname><given-names>VE</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Sheppard</surname><given-names>D</given-names></name><article-title>Tgf-beta is a critical mediator of acute lung injury</article-title><source>J Clin Invest</source><year>2001</year><volume>107</volume><fpage>1537</fpage><lpage>1544</lpage><pub-id pub-id-type="doi">10.1172/JCI11963</pub-id><pub-id pub-id-type="pmid">11413161</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Frank</surname><given-names>J</given-names></name><name><surname>Roux</surname><given-names>J</given-names></name><name><surname>Kawakatsu</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>G</given-names></name><name><surname>Dagenais</surname><given-names>A</given-names></name><name><surname>Berthiaume</surname><given-names>Y</given-names></name><name><surname>Howard</surname><given-names>M</given-names></name><name><surname>Canessa</surname><given-names>CM</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Sheppard</surname><given-names>D</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Pittet</surname><given-names>JF</given-names></name><article-title>Transforming growth factor-beta1 decreases expression of the epithelial sodium channel alphaenac and alveolar epithelial vectorial sodium and fluid transport via an erk1/2-dependent mechanism</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>43939</fpage><lpage>43950</lpage><pub-id pub-id-type="doi">10.1074/jbc.M304882200</pub-id><pub-id pub-id-type="pmid">12930837</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Willis</surname><given-names>BC</given-names></name><name><surname>Kim</surname><given-names>KJ</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liebler</surname><given-names>J</given-names></name><name><surname>Crandall</surname><given-names>ED</given-names></name><name><surname>Borok</surname><given-names>Z</given-names></name><article-title>Modulation of ion conductance and active transport by tgf-beta 1 in alveolar epithelial cell monolayers</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2003</year><volume>285</volume><fpage>L1192</fpage><lpage>L1200</lpage><pub-id pub-id-type="pmid">12730080</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Tossios</surname><given-names>P</given-names></name><name><surname>Bloch</surname><given-names>W</given-names></name><name><surname>Huebner</surname><given-names>A</given-names></name><name><surname>Raji</surname><given-names>MR</given-names></name><name><surname>Dodos</surname><given-names>F</given-names></name><name><surname>Klass</surname><given-names>O</given-names></name><name><surname>Suedkamp</surname><given-names>M</given-names></name><name><surname>Kasper</surname><given-names>SM</given-names></name><name><surname>Hellmich</surname><given-names>M</given-names></name><name><surname>Mehlhorn</surname><given-names>U</given-names></name><article-title>N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: Results of a randomized, double-blind, placebo-controlled clinical trial</article-title><source>J Thorac Cardiovasc Surg</source><year>2003</year><volume>126</volume><fpage>1513</fpage><lpage>1520</lpage><pub-id pub-id-type="doi">10.1016/S0022-5223(03)00968-1</pub-id><pub-id pub-id-type="pmid">14666027</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Cakir</surname><given-names>O</given-names></name><name><surname>Oruc</surname><given-names>A</given-names></name><name><surname>Kaya</surname><given-names>S</given-names></name><name><surname>Eren</surname><given-names>N</given-names></name><name><surname>Yildiz</surname><given-names>F</given-names></name><name><surname>Erdinc</surname><given-names>L</given-names></name><article-title>N-acetylcysteine reduces lung reperfusion injury after deep hypothermia and total circulatory arrest</article-title><source>J Card Surg</source><year>2004</year><volume>19</volume><fpage>221</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1111/j.0886-0440.2004.04059.x</pub-id><pub-id pub-id-type="pmid">15151648</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>JC</given-names></name><name><surname>Hong</surname><given-names>SW</given-names></name><name><surname>Shim</surname><given-names>JK</given-names></name><name><surname>Yoo</surname><given-names>KJ</given-names></name><name><surname>Chun</surname><given-names>DH</given-names></name><name><surname>Kwak</surname><given-names>YL</given-names></name><article-title>Effect of n-acetylcysteine on pulmonary function in patients undergoing off-pump coronary artery bypass surgery</article-title><source>Acta Anaesthesiol Scand</source><year>2011</year><volume>55</volume><fpage>452</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1111/j.1399-6576.2011.02407.x</pub-id><pub-id pub-id-type="pmid">21391924</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Klass</surname><given-names>O</given-names></name><name><surname>Fischer</surname><given-names>UM</given-names></name><name><surname>Antonyan</surname><given-names>A</given-names></name><name><surname>Bosse</surname><given-names>M</given-names></name><name><surname>Fischer</surname><given-names>JH</given-names></name><name><surname>Bloch</surname><given-names>W</given-names></name><name><surname>Mehlhorn</surname><given-names>U</given-names></name><article-title>Pneumocyte apoptosis induction during cardiopulmonary bypass: effective prevention by radical scavenging using n-acetylcysteine</article-title><source>J Invest Surg</source><year>2007</year><volume>20</volume><fpage>349</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1080/08941930701772165</pub-id><pub-id pub-id-type="pmid">18097876</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Williams</surname><given-names>EA</given-names></name><name><surname>Welty</surname><given-names>SE</given-names></name><name><surname>Geske</surname><given-names>RS</given-names></name><name><surname>Hubble</surname><given-names>CL</given-names></name><name><surname>Craig</surname><given-names>DM</given-names></name><name><surname>Quick</surname><given-names>G</given-names></name><name><surname>Meliones</surname><given-names>JN</given-names></name><name><surname>Cheifetz</surname><given-names>IM</given-names></name><article-title>Liquid lung ventilation reduces neutrophil sequestration in a neonatal swine model of cardiopulmonary bypass</article-title><source>Crit Care Med</source><year>2001</year><volume>29</volume><fpage>789</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1097/00003246-200104000-00021</pub-id><pub-id pub-id-type="pmid">11373470</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Kerbaul</surname><given-names>F</given-names></name><name><surname>Van der Linden</surname><given-names>P</given-names></name><name><surname>Pierre</surname><given-names>S</given-names></name><name><surname>Rondelet</surname><given-names>B</given-names></name><name><surname>Melot</surname><given-names>C</given-names></name><name><surname>Brimioulle</surname><given-names>S</given-names></name><name><surname>Naeije</surname><given-names>R</given-names></name><article-title>Prevention of hemodilution-induced inhibition of hypoxic pulmonary vasoconstriction by n-acetylcysteine in dogs</article-title><source>Anesth Analg</source><year>2004</year><volume>99</volume><fpage>547</fpage><lpage>551</lpage><comment>table of contents</comment><pub-id pub-id-type="pmid">15271736</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Mao</surname><given-names>ZM</given-names></name><name><surname>Song</surname><given-names>HY</given-names></name><name><surname>Yang</surname><given-names>LL</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>DF</given-names></name><name><surname>Zheng</surname><given-names>PY</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Ji</surname><given-names>G</given-names></name><article-title>Effects of the mixture of swertia pseudochinensis hara and silybum marianum gaertn extracts on ccl(4)-induced liver injury in rats with non-alcoholic fatty liver disease</article-title><source>Zhong Xi Yi Jie He Xue Bao</source><year>2012</year><volume>10</volume><fpage>193</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.3736/jcim20120210</pub-id><pub-id pub-id-type="pmid">22313887</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Takao</surname><given-names>Y</given-names></name><name><surname>Mikawa</surname><given-names>K</given-names></name><name><surname>Nishina</surname><given-names>K</given-names></name><name><surname>Obara</surname><given-names>H</given-names></name><article-title>Attenuation of acute lung injury with propofol in endotoxemia</article-title><source>Anesth Analg</source><year>2005</year><volume>100</volume><fpage>810</fpage><lpage>816</lpage><comment>table of contents</comment><pub-id pub-id-type="doi">10.1213/01.ANE.0000144775.19385.8C</pub-id><pub-id pub-id-type="pmid">15728072</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Gorgulu</surname><given-names>A</given-names></name><name><surname>Kiris</surname><given-names>T</given-names></name><name><surname>Unal</surname><given-names>F</given-names></name><name><surname>Turkoglu</surname><given-names>U</given-names></name><name><surname>Kucuk</surname><given-names>M</given-names></name><name><surname>Cobanoglu</surname><given-names>S</given-names></name><article-title>Superoxide dismutase activity and the effects of nbqx and cpp on lipid peroxidation in experimental spinal cord injury</article-title><source>Res Exp Med (Berl)</source><year>2000</year><volume>199</volume><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1007/s004330050126</pub-id><pub-id pub-id-type="pmid">10815757</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Chapple</surname><given-names>IL</given-names></name><article-title>Reactive oxygen species and antioxidants in inflammatory diseases</article-title><source>J Clin Periodontol</source><year>1997</year><volume>24</volume><fpage>287</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1111/j.1600-051X.1997.tb00760.x</pub-id><pub-id pub-id-type="pmid">9178107</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Kwong</surname><given-names>KY</given-names></name><name><surname>Literat</surname><given-names>A</given-names></name><name><surname>Zhu</surname><given-names>NL</given-names></name><name><surname>Huang</surname><given-names>HH</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Jones</surname><given-names>CA</given-names></name><name><surname>Minoo</surname><given-names>P</given-names></name><article-title>Expression of transforming growth factor beta (tgf-beta1) in human epithelial alveolar cells: A pro-inflammatory mediator independent pathway</article-title><source>Life Sci</source><year>2004</year><volume>74</volume><fpage>2941</fpage><lpage>2957</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2003.08.048</pub-id><pub-id pub-id-type="pmid">15051419</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Jardine</surname><given-names>H</given-names></name><name><surname>MacNee</surname><given-names>W</given-names></name><name><surname>Donaldson</surname><given-names>K</given-names></name><name><surname>Rahman</surname><given-names>I</given-names></name><article-title>Molecular mechanism of transforming growth factor (tgf)-beta1-induced glutathione depletion in alveolar epithelial cells. Involvement of ap-1/are and fra-1</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>21158</fpage><lpage>21166</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112145200</pub-id><pub-id pub-id-type="pmid">11912197</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Manabe</surname><given-names>E</given-names></name><name><surname>Handa</surname><given-names>O</given-names></name><name><surname>Naito</surname><given-names>Y</given-names></name><name><surname>Mizushima</surname><given-names>K</given-names></name><name><surname>Akagiri</surname><given-names>S</given-names></name><name><surname>Adachi</surname><given-names>S</given-names></name><name><surname>Takagi</surname><given-names>T</given-names></name><name><surname>Kokura</surname><given-names>S</given-names></name><name><surname>Maoka</surname><given-names>T</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><article-title>Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling</article-title><source>J Cell Biochem</source><year>2008</year><volume>103</volume><fpage>1925</fpage><lpage>1937</lpage><pub-id pub-id-type="doi">10.1002/jcb.21583</pub-id><pub-id pub-id-type="pmid">17955498</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Itagaki</surname><given-names>T</given-names></name><name><surname>Shimizu</surname><given-names>I</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Oshio</surname><given-names>A</given-names></name><name><surname>Tamaki</surname><given-names>K</given-names></name><name><surname>Fukuno</surname><given-names>H</given-names></name><name><surname>Honda</surname><given-names>H</given-names></name><name><surname>Okamura</surname><given-names>Y</given-names></name><name><surname>Ito</surname><given-names>S</given-names></name><article-title>Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells</article-title><source>Gut</source><year>2005</year><volume>54</volume><fpage>1782</fpage><lpage>1789</lpage><pub-id pub-id-type="pmid">16284289</pub-id></mixed-citation></ref></ref-list></back></article>